Comorbidities and medications of patients with chronic hepatitis C under specialist care in the UK-Reference-Cited by-同舟云学术

Comorbidities and medications of patients with chronic hepatitis C under specialist care in the UK

Published:2017-08-30 Issue:12 Volume:89 Page:2158-2164
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Hudson Benjamin¹^ORCID,Walker Alex J.²³,Irving William L.²³⁴

Affiliation:

1. University Hospitals Bristol NHS Foundation Trust; Bristol UK

2. School of Life Sciences; University of Nottingham; Nottingham UK

3. NIHR Nottingham Digestive Diseases Biomedical Research Unit; Nottingham UK

4. HCV Research UK; Nottingham UK

Funder

Gilead Sciences Ltd, UK

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.24848/fullpdf

Reference21 articles.

1. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010;Lozano;Lancet (London, England),2010

2. 2014 https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/337115/HCV_in_the_UK_2014_24_July.pdf

3. 2012 http://www.euro.who.int/en/health-topics/communicable-diseases/hivaids/publications/2012/barriers-and-facilitators-to-hepatitis-c-treatment-for-people-who-inject-drugs.-a-qualitative-study

4. https://www.gov.uk/government/publications/shooting-up-infections-among-people-who-inject-drugs-in-the-uk

5. Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: modelling the predicted impact of treatment under different scenarios;Harris;J Hepatol,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of comorbid conditions and prescribed chronic medications on the treatment plan for chronic hepatitis C infection: A cross‐sectional retrospective study;Health Science Reports;2024-04-29

2. Cross-Sectional Analysis and DDI Study of Drugs Used for Hepatitis C combined with Disease in a Hospital in Yunnan Province;Advances in Microbiology;2024

3. Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices;Pharmaceuticals;2022-02-18

4. Mortality among people who inject drugs: a prospective cohort followed over three decades in Baltimore, MD, USA;Addiction;2021-09-22

5. Comorbidities and Prescribed Medications in Korean Patients with Chronic Hepatitis C: A Nationwide, Population-Based Study;Gut and Liver;2021-03-15